In a report released on March 14, Jessica Fye from J.P. Morgan maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), ...

In a report released on March 6, Anupam Rama from J.P. Morgan maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a ...

Dynamic Biopsy non-invasively analyses dynamic biological processes within a specific organ or tissue to assess its health ...

In this episode of Denatured, BioSpace's Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of ...

With another JP Morgan in the rearview mirror ... Andrew Obershain, CEO of bluebird bio, said as much on stage. A year before the FDA approved his company’s gene therapy for sickle cell ...

atozsports #atozsportsdallas #dallascowboys #dak #cowboys #tonypollard #cowboysnation #ezekielelliott #dakprescott #dc4l #dcnation #americasteam #gocowboys #ceedeelamb #texas #micahparsons #thestar #c ...

Novelized accounts of historical figures’ lives are hugely popular. But do we really want to draw back the curtain on history ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

The partners defending President Trump are more well-known for advising large corporations or corporate executives in complex civil matters, especially securities litigation.

I often seek opportunities to expand my knowledge through organizations like Women In Bio, which is committed ... in industry conferences like the JP Morgan Healthcare Annual Conference—the ...